Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate the effect of semaglutide in women with Polycystic Ovarian Syndrome(PCOS ) and determine potential therapeutic benefits.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Methodist Health System
NCT03059173 · Polycystic Ovary Syndrome, Reproductive Medicine
NCT07483723 · Polycystic Ovary Syndrome, Glucose Profile, and more
NCT06793098 · Reproductive Age, PCOS (Polycystic Ovary Syndrome)
NCT06793085 · Reproductive Age, PCOS (Polycystic Ovary Syndrome)
NCT06047574 · Polycystic Ovary Syndrome
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions